What is the primary goal of ibutilide in the management of atrial fibrillation?

The primary goal of ibutilide in the management of atrial fibrillation is to restore normal rhythm. Ibutilide is a class III antiarrhythmic agent that works by prolonging the action potential duration and refractory period in the cardiac tissue, particularly in the atria. This mechanism helps to convert atrial fibrillation back to sinus rhythm by stabilizing the electrical activity in the heart.

While managing atrial fibrillation can involve other considerations, such as preventing thromboembolic events and maintaining hemodynamic stability, the specific therapeutic purpose of ibutilide is to achieve a normal electrical rhythm in patients experiencing this condition. Other treatment options may be utilized to address different aspects of atrial fibrillation, but the primary aim of ibutilide therapy is to restore the heart's rhythm to normal.